We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $202M
1-Year Est. Return 16.99%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$151M
AUM Growth
+$10.8M
Cap. Flow
+$7.79M
Cap. Flow %
5.14%
Top 10 Hldgs %
80.95%
Holding
48
New
–
Increased
3
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$5.08M
2
PATH icon
UiPath
PATH
+$2.84M
3
UBER icon
Uber
UBER
+$362K

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$362K
2
AMD icon
Advanced Micro Devices
AMD
+$83.2K
3
IOT icon
Samsara
IOT
+$44.3K

Sector Composition

Rank Sector Weight
1 Consumer Staples 39.64%
2 Technology 29.72%
3 Miscellaneous 13.28%
4 Consumer Discretionary 7.38%
5 Healthcare 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DDOG icon
26
Datadog
DDOG
$76.5B
$708K 0.47%
7,200
– –
MA icon
27
Mastercard
MA
$507B
$702K 0.46%
1,785
-965
-35% -$362K
PD icon
28
PagerDuty
PD
$1.07B
$686K 0.45%
30,517
– –
IOT icon
29
Samsara
IOT
$23.4B
$653K 0.43%
23,578
-2,000
-8% -$44.3K
TXG icon
30
10x Genomics
TXG
$8.16B
$626K 0.41%
11,208
– –
TWLO icon
31
Twilio
TWLO
$35.8B
$622K 0.41%
9,782
– –
GH icon
32
Guardant Health
GH
$21.7B
$570K 0.38%
15,933
– –
MBLY icon
33
Mobileye
MBLY
$7.28B
$502K 0.33%
13,067
– –
NOW icon
34
ServiceNow
NOW
$146B
$502K 0.33%
4,465
– –
PRME icon
35
Prime Medicine
PRME
$671M
$483K 0.32%
32,977
– –
SNOW icon
36
Snowflake
SNOW
$117B
$449K 0.3%
2,549
– –
TWST icon
37
Twist Bioscience
TWST
$8.21B
$429K 0.28%
20,970
– –
RLAY icon
38
Relay Therapeutics
RLAY
$4.17B
$399K 0.26%
31,807
– –
ABCL icon
39
AbCellera Biologics
ABCL
$3.7B
$368K 0.24%
56,976
– –
U icon
40
Unity
U
$18.3B
$362K 0.24%
8,327
– –
SMAR
41
DELISTED
Smartsheet Inc.
SMAR
$295K 0.19%
7,700
– –
RBLX icon
42
Roblox
RBLX
$30.9B
$292K 0.19%
7,241
– –
DNLI icon
43
Denali Therapeutics
DNLI
$3.56B
$283K 0.19%
9,601
– –
BEAM icon
44
Beam Therapeutics
BEAM
$3.06B
$258K 0.17%
8,067
– –
OLK
45
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$255K 0.17%
13,600
– –
DOCU
46
DocuSign
DOCU
$13.1B
$215K 0.14%
4,211
– –
FULC icon
47
Fulcrum Therapeutics
FULC
$294M
$86.2K 0.06%
26,127
– –
CELL
48
DELISTED
PhenomeX Inc. Common Stock
CELL
$14.6K 0.01%
29,772
– –
1
2

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
WPW
Winthrop Partners - WNY Buffalo, New York $202M AUM
HWA
Hilltop Wealth Advisors Chapel Hill, North Carolina $202M AUM 24.55% 1-Year Est. Return
DFG
Delphi Financial Group Wilmington, Delaware $202M AUM 21.25% 1-Year Est. Return
LAMC
Longview Asset Management (California) San Rafael, California $202M AUM 11.36% 1-Year Est. Return
FC
Farringdon Capital London, United Kingdom $202M AUM 4.1% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $203M AUM 60.82% 1-Year Est. Return
MRCM
Mill Road Capital Management Greenwich, Connecticut $203M AUM 79.43% 1-Year Est. Return

Brandywine Managers's Q2 2023 Portfolio in Review

As of Q2 2023, Brandywine Managers held 48 positions worth $151M, up 7.7% from $141M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Brandywine Managers deployed $7.79M of net new capital in Q2 2023, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Consumer Staples at 40% of assets, down from 42% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Mastercard, an estimated $362K trimmed.

  • Brandywine Managers added most to iShares MSCI ACWI ETF in Q2 2023, an estimated $5.08M increase.
  • Brandywine Managers's biggest Q2 2023 reduction was Mastercard, cutting an estimated $362K.
  • Brandywine Managers's ten largest holdings make up 81% of its $151M portfolio in Q2 2023.
  • Brandywine Managers opened 0 new positions and closed 0 in Q2 2023.
  • Brandywine Managers's portfolio value rose 7.7% quarter-over-quarter to $151M.

Based on Brandywine Managers's 13F filing for Q2 2023, filed 14 Aug 2023.